Prof. Dr. Rainer Fietkau



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Development of Admission to Radiotherapy Departments in Germany: A Population-Based Study of DRG Data (2021) Medenwald D, Fietkau R, Klautke G, Wuerschmidt F, Vordermark D Conference contribution Survey within the German Society for Radiation Oncology (DEGRO) on the Diagnosis and Treatment of Salivary Gland Carcinomas (2021) Von Der Gruen J, Roedel C, Balermpas P, Martin D, Semrau S, Fietkau R, Haderlein M Conference contribution Tumor Infiltrating Inflammatory Cells as a prognostic Factor in Glioblastoma (2021) Schnellhardt S, Zorob A, Polat B, Lisowski D, Daniel C, Monoranu CM, Fietkau R, Distel L Conference contribution No gender-specific Differences in the Radiation Sensitivity of Rectal Cancer Patients (2021) Schuster B, Geinitz H, Fietkau R, Distel L Conference contribution Radiation Sensitivity in Patients with Prostate Cancer (2021) Altmann JM, Schuster B, Geinitz H, Fietkau R, Distel L Conference contribution Individual Radiation Sensitivity of Tumor Patients with Rheumatoid Arthritis (2021) Rzepka D, Schuster B, Geinitz H, Fietkau R, Distel L Conference contribution Immunomodulatory and analgesic Effects of serial Radon-Baths in Patients with musculoskeletal Diseases: Investigations in the RAD-ON02 Study (2021) Donaubauer AJ, Becker I, Weikl L, Klein G, Fietkau R, Gaipl U, Frey B Conference contribution Physical Fitness in Combination with Age is an overwhelming prognostic Factor in Patients with advanced Rectal Cancer (2021) Fitz T, Sörgel C, Rutzner S, Fietkau R, Distel L Conference contribution Impact of Citrate-stabilized superparamagnetic Iron Oxide-Nanoparticles on Head and Neck Tumor Cell Lines in Combination Therapy with ionizing Radiation (2021) Schreiber C, Franzen T, Fietkau R, Tietze R, Stein R, Friedrich B, Distel L Conference contribution Experience gained with Durvalumab Maintenance Therapy after definitive Chemoradiotherapy in Patients with NSCLC: Survival- and Toxicity Data from Routine clinical Practice (2021) Lettmaier S, Hecht M, Weissmann T, Fietkau R Conference contribution